Cargando…
Are glomerular patients treated with immunosupressed drugs more protected against sever SARS-Covid -2?
Autores principales: | Agraz-Pamplona, Irene, Montoro, Bruno, Bury, Roxana, Soler, M Jose, Carro, Clara Garcia, Solans, Roser, Bolufer, Monica, Cortes, Josefina, Espinel, Eugenia, Seron, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508007/ https://www.ncbi.nlm.nih.gov/pubmed/32994058 http://dx.doi.org/10.1016/j.semarthrit.2020.09.004 |
Ejemplares similares
-
Acute interstitial nephritis associated with immune checkpoint inhibitors: a single-centre experience
por: Oleas, Diana, et al.
Publicado: (2020) -
The New Era for Reno-Cardiovascular Treatment in Type 2 Diabetes
por: García-Carro, Clara, et al.
Publicado: (2019) -
Safety of Obtaining an Extra Biobank Kidney Biopsy Core
por: Bermejo, Sheila, et al.
Publicado: (2022) -
Environmental contaminations and immunosupression
por: Ac̈aite, J., et al.
Publicado: (1995) -
COVID-19 in CKD Patients: Lessons from 553 CKD Patients with Biopsy-Proven Kidney Disease
por: Román, Juan León, et al.
Publicado: (2021)